OneDigital Investment Advisors LLC Has $672,000 Holdings in Axon Enterprise, Inc (NASDAQ:AXON)

OneDigital Investment Advisors LLC reduced its holdings in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 49.1% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 1,277 shares of the biotechnology company's stock after selling 1,233 shares during the quarter. OneDigital Investment Advisors LLC's holdings in Axon Enterprise were worth $672,000 as of its most recent filing with the SEC.

Other large investors also recently modified their holdings of the company. Fourth Dimension Wealth LLC bought a new position in shares of Axon Enterprise in the 4th quarter worth about $30,000. Bartlett & CO. Wealth Management LLC lifted its position in Axon Enterprise by 132.0% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company's stock valued at $31,000 after purchasing an additional 33 shares during the last quarter. Alpine Bank Wealth Management bought a new stake in Axon Enterprise in the 1st quarter valued at about $40,000. Elequin Capital LP bought a new stake in Axon Enterprise in the 4th quarter valued at about $46,000. Finally, CoreFirst Bank & Trust bought a new stake in Axon Enterprise in the 4th quarter valued at about $59,000. 79.08% of the stock is currently owned by institutional investors.

Axon Enterprise Price Performance

Shares of NASDAQ AXON traded down $3.37 during midday trading on Friday, reaching $729.62. The company's stock had a trading volume of 1,120,957 shares, compared to its average volume of 545,551. The company has a current ratio of 2.83, a quick ratio of 2.62 and a debt-to-equity ratio of 0.68. The company has a 50 day moving average price of $752.67 and a 200 day moving average price of $641.02. Axon Enterprise, Inc has a one year low of $279.02 and a one year high of $830.21. The company has a market cap of $56.80 billion, a price-to-earnings ratio of 176.24, a price-to-earnings-growth ratio of 83.99 and a beta of 1.29.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 EPS for the quarter, topping analysts' consensus estimates of $1.34 by $0.07. The business had revenue of $603.63 million for the quarter, compared to the consensus estimate of $585.67 million. Axon Enterprise had a net margin of 14.86% and a return on equity of 5.81%. The business's revenue for the quarter was up 31.3% on a year-over-year basis. During the same period in the previous year, the firm earned $1.15 EPS. On average, equities research analysts expect that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Analysts Set New Price Targets

Several brokerages recently weighed in on AXON. The Goldman Sachs Group lifted their price objective on shares of Axon Enterprise from $730.00 to $830.00 and gave the company a "buy" rating in a research report on Wednesday, May 14th. Needham & Company LLC lifted their price objective on shares of Axon Enterprise from $600.00 to $750.00 and gave the company a "buy" rating in a research report on Thursday, May 8th. Bank of America lifted their price objective on shares of Axon Enterprise from $750.00 to $895.00 and gave the company a "buy" rating in a research report on Wednesday, June 4th. Barclays lifted their price objective on shares of Axon Enterprise from $726.00 to $735.00 and gave the company an "overweight" rating in a research report on Friday, May 9th. Finally, Wolfe Research began coverage on shares of Axon Enterprise in a research report on Monday, July 7th. They issued an "outperform" rating on the stock. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and eleven have given a buy rating to the company. According to data from MarketBeat, Axon Enterprise currently has a consensus rating of "Moderate Buy" and a consensus price target of $699.55.

Insider Activity

In related news, CEO Patrick W. Smith sold 10,000 shares of the company's stock in a transaction on Monday, April 21st. The shares were sold at an average price of $540.99, for a total transaction of $5,409,900.00. Following the completion of the sale, the chief executive officer directly owned 3,063,982 shares of the company's stock, valued at approximately $1,657,583,622.18. This represents a 0.33% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Michael Garnreiter sold 5,913 shares of the company's stock in a transaction on Wednesday, June 4th. The stock was sold at an average price of $760.00, for a total transaction of $4,493,880.00. Following the sale, the director directly owned 17,740 shares of the company's stock, valued at approximately $13,482,400. This represents a 25.00% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 44,642 shares of company stock valued at $30,500,428 in the last three months. 4.40% of the stock is currently owned by insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.